FAQs

08 Jan Ylan Kazi to Join Antibiotic Adjuvant’s Advisory Board

Gainesville, FL – January 8th, 2019 Antibiotic Adjuvant announced today that Ylan Kazi will join the company as a Data Science Advisor. Ylan will advise the team on Machine Learning strategy and architecture and brings with him unique healthcare and data science skills that the team will be able to leverage to improve SmartSteward™.

“I think that antibiotic resistance will be a public health crisis now and in the future. Antibiotic Adjuvant has a team of passionate, committed experts that share in the vision of combating antibiotic resistance for vulnerable populations, and I’m excited to use my expertise to help them succeed.” – Ylan Kazi

Currently, Ylan Kazi is the Director of Data Science and Machine Learning for UnitedHealthcare, where he leads a team of data scientists that apply machine learning to challenging healthcare business problems. In his role, he creates the strategy for how to apply machine learning to Medicare Part D and improve patient health outcomes. He guides his team on the creation of novel machine learning solutions for healthcare that will improve health outcomes for patients and increase ROI for the organization.

About Antibiotic Adjuvant: Antibiotic Adjuvant is a digital health startup addressing the problem of antibiotic misuse to reduce antibiotic resistance, improve patient outcomes, and reduce the patient cost of care. Our first product, SmartSteward™, optimizes antibiotic use on skilled nursing facilities. We have 3 active pilots and are developing our platform with our experienced team and selected nursing home staff including physicians, nurses and pharmacists.

About

SmartSteward™ is the first and only intelligent software specifically designed to detect malicious viruses in skilled nursing facilities as well as serve as a decision support platform, delivering data to the doctors and nurses at the moment they need it.